The link between anemia and adverse outcomes in patients with acute coronary syndrome

References

• Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser. 1968;405:5–37.
   PubMedGoogle Scholar
• Pasricha S-R, Colman K, Centeno-Tablante E, et al. Revisiting WHO haemoglobin thresholds to define anaemia in clinical medicine and public health. Lancet Haematol. 2018;5:e60–e62.
   PubMed Web of Science ®Google Scholar
• WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity [Internet]. WHO. [ cited 2018 Jun 19]. Available from: http://www.who.int/vmnis/indicators/haemoglobin/en/
   Google Scholar
• Recommendations to prevent and control iron deficiency in the United States [Internet]. [ cited 2018 Jun 19]. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/00051880.htm#00003036.htm.
   Google Scholar
• Hoffman R, Benz EJ, Shattil SJ, et al. Hematology: basic principles and practices. New York (NY): Churchill-Livingstone; 2004.
   Google Scholar
• Bates I, Lewis SM. Dacie and Lewis practical haematology. Amsterdam, Netherland: Elsevier; 2011.
   Google Scholar
• Ryan DH. Chapter 2: examination of blood cells. In: McGraw-Hill Education, Eds. Williams haematology. NewYor, NY: McGraw-Hill; 2015.
   Google Scholar
• Anemia - symptoms and causes - Mayo clinic [Internet]. [ cited 2018 Jun 19]. Available from: https://www.mayoclinic.org/diseases-conditions/anemia/symptoms-causes/syc-20351360
   Google Scholar
• Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood. 2006;107:1747–1750.
   PubMed Web of Science ®Google Scholar
• Patel KV. Epidemiology of anemia in older adults. Semin Hematol. 2008;45:210–217.
   PubMed Web of Science ®Google Scholar
• Wu WC, Rathore SS, Wang Y, et al. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med. 2001;345:1230–1236.
   PubMed Web of Science ®Google Scholar
• Lipsic E, van der Horst ICC, Voors AA, et al. Hemoglobin levels and 30-day mortality in patients after myocardial infarction. Int J Cardiol. 2005;100:289–292.
   PubMed Web of Science ®Google Scholar
• Archbold RA, Balami D, Al-Hajiri A, et al. Hemoglobin concentration is an independent determinant of heart failure in acute coronary syndromes: cohort analysis of 2310 patients. Am Heart J. 2006;152:1091–1095.
   PubMed Web of Science ®Google Scholar
• Steinvil A, Banai S, Leshem-Rubinow E, et al. The development of anemia of inflammation during acute myocardial infarction. Int J Cardiol. 2012;156:160–164.
   PubMed Web of Science ®Google Scholar
• Lawler PR, Filion KB, Dourian T, et al. Anemia and mortality in acute coronary syndromes: a systematic review and meta-analysis. Am Heart J. 2013;165: 143–153.e5.
   PubMed Web of Science ®Google Scholar
• Kunadian V, Mehran R, Lincoff AM, et al. Effect of anemia on frequency of short- and long-term clinical events in acute coronary syndromes (from the acute catheterization and urgent intervention triage strategy trial). Am J Cardiol. 2014;114:1823–1829.
   PubMed Web of Science ®Google Scholar
• Sulaiman K, Prashanth P, Al-Zakwani I, et al. Impact of anemia on in-hospital, one-month and one-year mortality in patients with acute coronary syndrome from the Middle East. Clin Med Res. 2012;10:65–71.
   PubMedGoogle Scholar
• Wang X, Qiu M, Qi J, et al. Impact of anemia on long-term ischemic events and bleeding events in patients undergoing percutaneous coronary intervention: a system review and meta-analysis. J Thorac Dis. 2015;7:2041–2052.
   PubMed Web of Science ®Google Scholar
• Sudarsky D, Sudarsky M, Matezky S, et al. Impact of early invasive approach on outcomes of patients with acute coronary syndrome and baseline anemia: analysis from the ACSIS registry. J Interv Cardiol. 2015;28:315–325.
   PubMed Web of Science ®Google Scholar
• Ducrocq G, Puymirat E, Steg PG, et al. Blood transfusion, bleeding, anemia, and survival in patients with acute myocardial infarction: FAST-MI registry. Am Heart J. 2015;170:726–734.e2.
   PubMed Web of Science ®Google Scholar
• Yazji K, Abdul F, Elangovan S, et al. Baseline anemia in patients undergoing percutaneous coronary intervention after an acute coronary syndrome-A paradox of high bleeding risk, high ischemic risk, and complex coronary disease. J Interv Cardiol. 2017;30:491–499.
   PubMed Web of Science ®Google Scholar
• Mamas MA, Kwok CS, Kontopantelis E, et al. Relationship between anemia and mortality outcomes in a national acute coronary syndrome cohort: insights from the UK myocardial ischemia national audit project registry. J Am Heart Assoc. 2016;5(11):pii: e003348.
   Web of Science ®Google Scholar
• Shiraishi J, Kohno Y, Nakamura T, et al. Prognostic impact of chronic kidney disease and anemia at admission on in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction. Int Heart J. 2014;55:301–306.
   PubMed Web of Science ®Google Scholar
• Morici N, Cantoni S, Antonicelli R, et al. Anemia in octogenarians with non-ST elevation acute coronary syndrome: aging or disease? Int J Cardiol. 2014;176:1147–1149.
   PubMed Web of Science ®Google Scholar
• Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357:2001–2015.
   PubMed Web of Science ®Google Scholar
• Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045–1057.
   PubMed Web of Science ®Google Scholar
• Park KW, Chae I-H, Lim D-S, et al. Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of xience/promus versus cypher to reduce late loss after stenting) randomized trial. J Am Coll Cardiol. 2011;58:1844–1854.
   PubMedGoogle Scholar
• Urban P, Meredith IT, Abizaid A, et al. Polymer-free drug-coated coronary stents in patients at high bleeding risk. N Engl J Med. 2015;373:2038–2047.
   PubMed Web of Science ®Google Scholar
• Valgimigli M, Patialiakas A, Thury A, et al. Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates. J Am Coll Cardiol. 2015;65:805–815.
   PubMed Web of Science ®Google Scholar
• Gibson CM, Mehran R, Bode C, et al. Prevention of bleeding in patients with atrial fibrillation undergoing PCI. N Engl J Med. 2016;375:2423–2434.
   PubMed Web of Science ®Google Scholar
• Cannon CP, Bhatt DL, Oldgren J, et al. Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med. 2017;377:1513–1524.
   PubMed Web of Science ®Google Scholar
• Baber U, Mehran R, Giustino G, et al. Coronary thrombosis and major bleeding after PCI with drug-eluting stents: risk scores from PARIS. J Am Coll Cardiol. 2016;67:2224–2234.
   PubMed Web of Science ®Google Scholar
• Aronson D, Suleiman M, Agmon Y, et al. Changes in haemoglobin levels during hospital course and long-term outcome after acute myocardial infarction. Eur Heart J. 2007;28:1289–1296.
   PubMedGoogle Scholar
• Salisbury AC, Alexander KP, Reid KJ, et al. Incidence, correlates, and outcomes of acute, hospital-acquired anemia in patients with acute myocardial infarction. Circ Cardiovasc Qual Outcomes. 2010;3:337–346.
   PubMed Web of Science ®Google Scholar
• Salisbury AC, Reid KJ, Alexander KP, et al. Diagnostic blood loss from phlebotomy and hospital-acquired anemia during acute myocardial infarction. Arch Intern Med. 2011;171:1646–1653.
   PubMedGoogle Scholar
• Shacham Y, Leshem-Rubinow E, Ben-Assa E, et al. Lower admission hemoglobin levels are associated with longer symptom duration in acute ST-elevation myocardial infarction. Clin Cardiol. 2014;37:73–77.
   PubMed Web of Science ®Google Scholar
• Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382:260–272.
   PubMed Web of Science ®Google Scholar
• Stauffer ME, Fan T. Prevalence of anemia in chronic kidney disease in the United States. PLoS ONE. 2014;9:e84943.
   PubMed Web of Science ®Google Scholar
• Briasoulis A, Bakris GL. Chronic kidney disease as a coronary artery disease risk equivalent. Curr Cardiol Rep. 2013;15:340.
   PubMed Web of Science ®Google Scholar
• Kurihara O, Okamatsu K, Mizuno K, et al. Coronary atherosclerosis and risk of acute coronary syndromes in chronic kidney disease using angioscopy and the kidney disease: improving global outcomes (KDIGO) classification. Atherosclerosis. 2015;243:567–572.
   PubMed Web of Science ®Google Scholar
• Di Lullo L, House A, Gorini A, et al. Chronic kidney disease and cardiovascular complications. Heart Fail Rev. 2015;20:259–272.
   PubMed Web of Science ®Google Scholar
• Mehdi U, Toto RD. Anemia, diabetes, and chronic kidney disease. Diabetes Care. 2009;32:1320–1326.
   PubMed Web of Science ®Google Scholar
• Grossman C, Dovrish Z, Koren-Morag N, et al. Diabetes mellitus with normal renal function is associated with anaemia. Diabetes Metab Res Rev. 2014;30:291–296.
   PubMed Web of Science ®Google Scholar
• Cappellini MD, Motta I. Anemia in clinical practice-definition and classification: does hemoglobin change with aging?. Semin Hematol. 2015;52:261–269.
   PubMed Web of Science ®Google Scholar
• Stauder R, Valent P, Theurl I. Anemia at older age: etiologies, clinical implications, and management. Blood. 2018;131:505–514.
   PubMed Web of Science ®Google Scholar
• Nanayakkara S, Marwick TH, Kaye DM. The ageing heart: the systemic and coronary circulation. Heart. 2018;104:370–376.
   PubMed Web of Science ®Google Scholar
• Kaiafa G, Kanellos I, Savopoulos C, et al. Is anemia a new cardiovascular risk factor? Int J Cardiol. 2015;186:117–124.
   PubMed Web of Science ®Google Scholar
• Rymer JA, Rao SV. Anemia and coronary artery disease: pathophysiology, prognosis, and treatment. Coron Artery Dis. 2018;29:161–167.
   PubMed Web of Science ®Google Scholar
• Sarnak MJ, Tighiouart H, Manjunath G, et al. Anemia as a risk factor for cardiovascular disease in the atherosclerosis risk in communities (ARIC) study. J Am Coll Cardiol. 2002;40:27–33.
   PubMed Web of Science ®Google Scholar
• Hong YJ, Jeong MH, Choi YH, et al. Relation between anemia and vulnerable coronary plaque components in patients with acute coronary syndrome: virtual histology-intravascular ultrasound analysis. J Korean Med Sci. 2012;27:370–376.
   PubMed Web of Science ®Google Scholar
• Uchida Y, Ichimiya S, Ishii H, et al. Impact of admission anemia on coronary microcirculation and clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Int Heart J. 2015;56:381–388.
   PubMed Web of Science ®Google Scholar
• Solomon A, Blum A, Peleg A, et al. Endothelial progenitor cells are suppressed in anemic patients with acute coronary syndrome. Am J Med. 2012;125:604–611.
   PubMed Web of Science ®Google Scholar
• Belziti CA. Prevalence of anemia in heart failure and its effects on prognosis. Expert Rev Cardiovasc Ther. 2009;7:131–138.
   PubMedGoogle Scholar
• Brener SJ, Mehran R, Dangas GD, et al. Relation of baseline hemoglobin levels and adverse events in patients with acute coronary syndromes (from the acute catheterization and urgent intervention triage strategy and harmonizing outcomes with revascularization and stents in acute myocardial infarction trials). Am J Cardiol. 2017;119:1710–1716.
   PubMed Web of Science ®Google Scholar
• Kwok CS, Tiong D, Pradhan A, et al. Meta-analysis of the prognostic impact of anemia in patients undergoing percutaneous coronary intervention. Am J Cardiol. 2016;118:610–620.
   PubMed Web of Science ®Google Scholar
• Sabatine MS, Morrow DA, Giugliano RP, et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation. 2005;111:2042–2049.
   PubMed Web of Science ®Google Scholar
• Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium. Circulation. 2011;123:2736–2747.
   PubMed Web of Science ®Google Scholar
• Mehran R, Pocock S, Nikolsky E, et al. Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials. JACC Cardiovasc Interv. 2011;4:654–664.
   PubMed Web of Science ®Google Scholar
• Valgimigli M, Bueno H, Byrne RA, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the task force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018;39:213–260.
   PubMed Web of Science ®Google Scholar
• Levine GN, Bates ER, Bittl JA, et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. J Am Coll Cardiol. 2016;68:1082–1115.
   PubMed Web of Science ®Google Scholar
• Giustino G, Kirtane AJ, Baber U, et al. Impact of anemia on platelet reactivity and ischemic and bleeding risk: from the assessment of dual antiplatelet therapy with drug-eluting stents study. Am J Cardiol. 2016;117:1877–1883.
   PubMed Web of Science ®Google Scholar
• Wadowski PP, Kopp CW, Koppensteiner R, et al. Decreased platelet inhibition by P2Y12 receptor blockers in anaemia. Eur J Clin Invest. 2018 Jan;48(1). doi: 10.1111/eci.12861.
   Web of Science ®Google Scholar
• Guerrero C, Garay A, Ariza-Solé A, et al. Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: insights from the RENAMI registry. Thromb Res. 2018;167:142–148.
   PubMed Web of Science ®Google Scholar
• Howlett JG. Recognition and treatment of anemia in the setting of heart failure due to systolic left ventricular dysfunction. Expert Rev Cardiovasc Ther. 2008;6:199–208.
   PubMedGoogle Scholar
• Macchia A, Mariani J, Comignani PD, et al. Anemia and chronic heart failure: from pathophysiologic mechanisms to clinical trial designs. Expert Rev Cardiovasc Ther. 2009;7:139–145.
   PubMedGoogle Scholar
• Rodríguez-Mañero M, Cordero A, Kreidieh O, et al. Proposal of a novel clinical score to predict heart failure incidence in long-term survivors of acute coronary syndromes. Int J Cardiol. 2017;249:301–307.
   PubMed Web of Science ®Google Scholar
• Dangas G, Chandrasekhar J. Real dilemmas regarding blood transfusion. JACC Cardiovasc Interv. 2015;8:447–449.
   PubMed Web of Science ®Google Scholar
• Doyle BJ, Rihal CS, Gastineau DA, et al. Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice. J Am Coll Cardiol. 2009;53:2019–2027.
   PubMed Web of Science ®Google Scholar
• Twomley KM, Rao SV, Becker RC. Proinflammatory, immunomodulating, and prothrombotic properties of anemia and red blood cell transfusions. J Thromb Thrombolysis. 2006;21:167–174.
   PubMed Web of Science ®Google Scholar
• Nielsen HJ, Reimert C, Pedersen AN, et al. Leucocyte-derived bioactive substances in fresh frozen plasma. Br J Anaesth. 1997;78:548–552.
   PubMed Web of Science ®Google Scholar
• Silvain J, Pena A, Cayla G, et al. Impact of red blood cell transfusion on platelet activation and aggregation in healthy volunteers: results of the TRANSFUSION study. Eur Heart J. 2010;31:2816–2821.
   PubMed Web of Science ®Google Scholar
• Silvain J, Abtan J, Kerneis M, et al. Impact of red blood cell transfusion on platelet aggregation and inflammatory response in anemic coronary and noncoronary patients: the TRANSFUSION-2 study (impact of transfusion of red blood cell on platelet activation and aggregation studied with flow cytometry use and light transmission aggregometry). J Am Coll Cardiol. 2014;63:1289–1296.
   PubMed Web of Science ®Google Scholar
• Karrowni W, Vora AN, Dai D, et al. Blood transfusion and the risk of acute kidney injury among patients with acute coronary syndrome undergoing percutaneous coronary intervention. Circ Cardiovasc Interv. 2016;9(9):pii: e003279.
   PubMed Web of Science ®Google Scholar
• Kwok CS, Sherwood MW, Watson SM, et al. Blood transfusion after percutaneous coronary intervention and risk of subsequent adverse outcomes: a systematic review and meta-analysis. JACC Cardiovasc Interv. 2015;8:436–446.
   PubMed Web of Science ®Google Scholar
• Sherwood MW, Wang Y, Curtis JP, et al. Patterns and outcomes of red blood cell transfusion in patients undergoing percutaneous coronary intervention. JAMA. 2014;311:836–843.
   PubMed Web of Science ®Google Scholar
• Kansagara D, Dyer E, Englander H, et al. Treatment of anemia in patients with heart disease: a systematic review. Ann Intern Med. 2013;159:746–757.
   PubMed Web of Science ®Google Scholar
• Hébert PC, Yetisir E, Martin C, et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med. 2001;29:227–234.
   PubMed Web of Science ®Google Scholar
• Cooper HA, Rao SV, Greenberg MD, et al. Conservative versus liberal red cell transfusion in acute myocardial infarction (the CRIT Randomized Pilot Study). Am J Cardiol. 2011;108:1108–1111.
   PubMed Web of Science ®Google Scholar
• Carson JL, Brooks MM, Abbott JD, et al. Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. Am Heart J. 2013;165:964–971.e1.
   PubMed Web of Science ®Google Scholar
• Carson JL, Guyatt G, Heddle NM, et al. Clinical practice guidelines from the AABB: red blood cell transfusion thresholds and storage. JAMA. 2016;316:2025–2035.
   PubMed Web of Science ®Google Scholar
• Toblli JE, Lombraña A, Duarte P, et al. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol. 2007;50:1657–1665.
   PubMed Web of Science ®Google Scholar
• Okonko DO, Grzeslo A, Witkowski T, et al. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. J Am Coll Cardiol. 2008;51:103–112.
   PubMed Web of Science ®Google Scholar
• Anker SD, Comin Colet J, Filippatos G, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009;361:2436–2448.
   PubMed Web of Science ®Google Scholar
• Litton E, Xiao J, Ho KM. Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials. BMJ. 2013;347:f4822.
   PubMed Web of Science ®Google Scholar
• Swedberg K, Young JB, Anand IS, et al. Treatment of anemia with darbepoetin alfa in systolic heart failure. N Engl J Med. 2013;368:1210–1219.
   PubMed Web of Science ®Google Scholar
• Najjar SS, Rao SV, Melloni C, et al. Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial. JAMA. 2011;305:1863–1872.
   PubMed Web of Science ®Google Scholar
• Jolly SS, Yusuf S, Cairns J, et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet. 2011;377:1409–1420.
   PubMed Web of Science ®Google Scholar
• Romagnoli E, Biondi-Zoccai G, Sciahbasi A, et al. Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial versus femoral randomized investigation in ST-elevation acute coronary syndrome) study. J Am Coll Cardiol. 2012;60:2481–2489.
   PubMed Web of Science ®Google Scholar
• Valgimigli M, Frigoli E, Leonardi S, et al. Bivalirudin or unfractionated heparin in acute coronary syndromes. N Engl J Med. 2015;373:997–1009.
   PubMed Web of Science ®Google Scholar
• Silvain J, Beygui F, Barthélémy O, et al. Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis. BMJ. 2012;344:e553.
   PubMed Web of Science ®Google Scholar
• Stone GW, Witzenbichler B, Guagliumi G, et al. Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial. Lancet. 2011;377:2193–2204.
   PubMed Web of Science ®Google Scholar
• Stone GW, White HD, Ohman EM, et al. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial. Lancet. 2007;369:907–919.
   PubMed Web of Science ®Google Scholar
• Zeitouni M, Kerneis M, Nafee T, et al. Anticoagulation in acute coronary syndrome-state of the art. Prog Cardiovasc Dis. 2018;60(4–5):508–513.
   PubMed Web of Science ®Google Scholar
• Stone GW, Witzenbichler B, Guagliumi G, et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med. 2008;358:2218–2230.
   PubMed Web of Science ®Google Scholar
• Costa F, van Klaveren D, James S, et al. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Lancet. 2017;389:1025–1034.
   PubMed Web of Science ®Google Scholar
• Abu-Assi E, Raposeiras-Roubin S, Cobas-Paz R, et al. Assessing the performance of the PRECISE-DAPT and PARIS risk scores for predicting one-year out-of-hospital bleeding in acute coronary syndrome patients. EuroIntervention. 2018;13:1914–1922.
   PubMed Web of Science ®Google Scholar
• Stucchi M, Cantoni S, Piccinelli E, et al. Anemia and acute coronary syndrome: current perspectives. Vasc Health Risk Manag. 2018;14:109–118.
   PubMed Web of Science ®Google Scholar
• Ariotti S, Adamo M, Costa F, et al. Is bare-metal stent implantation still justifiable in high bleeding risk patients undergoing percutaneous coronary intervention? A pre-specified analysis from the ZEUS trial. JACC Cardiovasc Interv. 2016;9:426–436.
   PubMed Web of Science ®Google Scholar
• Varenne O, Cook S, Sideris G, et al. Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial. Lancet. 2018;391:41–50.
   PubMed Web of Science ®Google Scholar
• Farhan S, Baber U, Mehran R. Anemia and acute coronary syndrome: time for intervention studies. J Am Heart Assoc. 2016;5(11):pii: e004908.
   PubMed Web of Science ®Google Scholar